How many years of comparable data are there for Central African Republic and Libya?

18 years are reported by both, from 2000 to 2023.

Where does this data come from?

UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Central African Republic vs Libya: Antiretroviral therapy coverage for PMTCT

Central African Republic

69.0%

in 2024

Libya

70.0%

in 2023

Central African Republic rank

52nd

Libya rank

51st

Antiretroviral therapy coverage for PMTCT over time

Central African Republic
Libya

How they compare

Libya currently reports 70.0% against 69.0% in Central African Republic, a difference of 1.0%.

The two have swapped places 4 times across 18 shared years of data; in 2000 it was Libya ahead.

Central African Republic ranks 52nd and Libya ranks 51st of 84 countries.

Across the 3 decades both report, Central African Republic averaged higher in 1 and Libya in 2.

Head to head by decade

Decade	Central African Republic	Libya	Difference	Ahead
2000s	9.0%	0.0%	9.0%	Central African Republic
2010s	54.8%	65.8%	11.0%	Libya
2020s	56.8%	71.0%	14.2%	Libya

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage for pmtct, Central African Republic or Libya?: Libya, at 70.0% against 69.0% in Central African Republic as of 2023.
What is the difference in antiretroviral therapy coverage for pmtct between Central African Republic and Libya?: 1.0%, with Libya ahead.
How many years of comparable data are there for Central African Republic and Libya?: 18 years are reported by both, from 2000 to 2023.
How do Central African Republic and Libya rank globally for antiretroviral therapy coverage for pmtct?: Central African Republic ranks 52nd and Libya ranks 51st of 84 countries.
Where does this data come from?: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Libya: Antiretroviral therapy coverage for PMTCT. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/central-african-republic/libya/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/central-african-republic/libya/">Central African Republic vs Libya: Antiretroviral therapy coverage for PMTCT</a> — Statizoid

About this data

Indicator: Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit: % of pregnant women living with HIV
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 99 places, 2,393 data points, 2000–2024
Last refreshed: 17 September 2026

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).